Skip to content

Hamstrings Autograft Versus Tibialis Allograft for Reconstruction of Anterior Cruciate Ligament

Hamstrings Autograft Versus Tibialis Allograft for Reconstruction of Anterior Cruciate Ligament: Randomized Clinical Trial With 2 Year Follow-up

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00510848
Enrollment
40
Registered
2007-08-02
Start date
2007-08-31
Completion date
2015-07-31
Last updated
2022-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rupture of the Anterior Cruciate Ligament With Instability of the Knee Joint

Brief summary

Patients suffering from a rupture of the anterior cruciate ligament (ACL) with instability of the knee joint are treated with an operative ACL-reconstruction: one group of patients with a reconstruction with an autograft tendon (hamstrings), the other group with a reconstruction with an allograft tendon (tibialis posterior). The same surgical technique, the same fixation technique and the same rehabilitation protocol will be used in both groups. Follow-up will be done during 2 years.

Interventions

PROCEDUREautograft tendon

Reconstruction with an autograft tendon (hamstrings)

PROCEDUREallograft tendon

Reconstruction with an allograft tendon (tibialis posterior)

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* isolated rupture of the anterior cruciate ligament with instability of the knee joint * meniscal tear possible to suture * partial meniscectomies

Exclusion criteria

* chronic laxity (more than 9 months) * associated collateral laxity (grade III) * subtotal or total meniscectomy * infection or inflammatory disease of the knee joint * large cartilage lesion

Design outcomes

Primary

MeasureTime frame
X-ray, CT-scan, KT100012 months

Secondary

MeasureTime frame
X-rays, CT-scan, KT100024 months

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026